TP53 and amyotrophic lateral sclerosis: Moreover, p53 cerebellar reduction in relation to poly-PR and poly-GR accumulation in C9orf72 ALS/FTD-patient remains unclear, but further research may highlight potential therapies which could be applicable to other diseases such as spinal muscular atrophy and Purkinje cell degeneration [86, 87].